Clinical trial
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
NCT00158132 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00158132 |
|---|---|
| Title | Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2 |
| Official title | A Double-Blind, Placebo Controlled Trial of Propranolol and Amantadine for the Treatment of Cocaine Dependent Subjects With Severe Cocaine Withdrawal Symptoms |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Propranolol, Amantadine, Placebo |
| Enrollment | 199 |
| Start date | Sep 1, 1999 |
| Primary completion | Mar 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: